Meeting
2017 ASCO Annual Meeting
Microvessel density as a prognostic marker in high-risk renal cell carcinoma.
Authors
Sarah A. Weiss
Yale School of Medicine, New Haven, CT
Sarah A. Weiss , Maneka Puligandla , Lucia Jilaveanu , Naomi B. Haas , Xin Victoria Wang , Christopher Zito , Marta Boeke , Veronique Neumeister , Judith Manola , Robert S. DiPaola , Harriet M. Kluger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4565)
DOI
10.1200/JCO.2017.35.15_suppl.4565
Abstract #
4565
Poster Bd #
243
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Biomarker analysis from a phase III trial (GOLD) of dovitinib (Dov) versus sorafenib (Sor) in patients with metastatic renal cell carcinoma after one prior VEGF pathway–targeted therapy and one prior mTOR inhibitor therapy.
First Author: Bernard J. Escudier
Poster
2020 Genitourinary Cancers Symposium
Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.
First Author: Rabbia Siddiqi
Poster
2019 Genitourinary Cancers Symposium
Angiogenic factor and cytokine analysis among patients with renal cell carcinoma treated with adjuvant VEGFR TKIs.
First Author: Wenxin Xu
Poster
2018 Genitourinary Cancers Symposium
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
First Author: Daniel Vargas Almeida